Myofibrillar MyopathySymptoms, Doctors, Treatments, Advances & More
Myofibrillar Myopathy Overview
Learn About Myofibrillar Myopathy
- Myofibrillar myopathy
- Alpha Beta crystallinopathy (type)
- Desmin related myopathy (former name)
- Desmin storage myopathy (former name)
- Desminopathy (type)
- Filaminopathy (type)
- Myotilinopathy (type)
- Protein surplus myopathy (former name)
- Zaspopathy (type)
Andreas Brodehl practices practicing medicine in Bochum, Germany. Mr. Brodehl is rated as an Elite expert by MediFind in the treatment of Myofibrillar Myopathy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Restrictive Cardiomyopathy (RCM), Myofibrillar Myopathy, Cardiomyopathy, Dilated Cardiomyopathy (DCM), and Heart Transplant.
Jan Gummert practices practicing medicine in Bad Oeynhausen, Germany. Gummert is rated as a Distinguished expert by MediFind in the treatment of Myofibrillar Myopathy. They are also highly rated in 24 other conditions, according to our data. Their clinical expertise encompasses Heart Failure, Myofibrillar Myopathy, Cardiomyopathy, Heart Transplant, and Heart Bypass Surgery.
Kennedy Krieger Institute
Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy. Dr. Leung is rated as an Advanced provider by MediFind in the treatment of Myofibrillar Myopathy. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, and Dysferlinopathy. Dr. Leung is board certified in American Board Of Psychiatry And Neurology.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

